re: Ann: MAK: Seventh Supplementary Bidders S... " the Increased Offer now falls within the valuation range for UCL Shares determined by the Independent Expert."
Irrespective of what we get from an amended valuation report is this really sufficient grounds to recommend the takeover offer? Not to most UCL holders to date who have shown no interest in Wonarah and thus consider the immediate dilution of ownership share of Sandpiper as unacceptable. To them a proper takeover premium is required and falling within a valuation range that essentially doesn't allow for potential income from Sandpiper just doesn't cut it.
- Forums
- ASX - By Stock
- AEV
- Ann: MAK: Seventh Supplementary Bidders Statement
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $25.42M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $3.935K | 437.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 7234999 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 202000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 7234999 | 0.008 |
4 | 1147490 | 0.007 |
5 | 2585000 | 0.006 |
2 | 1300000 | 0.005 |
2 | 1450000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 6540823 | 13 |
0.011 | 1100099 | 2 |
0.012 | 2544954 | 2 |
0.013 | 1234269 | 4 |
0.014 | 571499 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online